Mild depressive symptoms (score =9 on the Beck Depression Inventory-IA) Mental and Behavioural Disorders
Conditions
Interventions
This study is a randomised controlled single-centre service-based trial of an existing iCBT program (“Mental Hub iCBT for Depression”). The aim is to examine if this treatment can reduce the number of
however, blinding for treatment allocation will not be possible as it will be clear to the referring nurse as well as the patient whether the patient has been allocated to iCBT treatment or the contro
Sponsors
University of Helsinki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 04/03/2020: 1. Visiting a nurse at Occupational Health Helsinki 2. Being 18- to-34 years old at the time of recruitment 3. Continuously employed by the City of Helsinki for at least 6 months before recruitment 4. Score = 9 on the Beck Depression Inventory-IA (BDI-IA) Previous participant inclusion criteria from 04/06/2019 to 04/03/2020: 1. Visiting a nurse at Occupational Health Helsinki 2. Being 18- to-34 years old at the time of recruitment 3. Continuously employed by the City of Helsinki for at least 6 months before recruitment 4. Score = 9 on the Beck Depression Inventory 21 Previous participant inclusion criteria: 1. Visiting an Occupational Health nurse 2. Being 18- to-34 years old at the time of recruitment 3. Continuously employed by the City of Helsinki for at least 4 months before recruitment 4. Score = 9 on the Beck Depression Inventory 21
Exclusion criteria
Exclusion criteria: Current participant exclusion criteria as of 04/03/2020: 1. Current high risk for suicide 2. Psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive-compulsive disorder, personality disorder 3. Not able to read Finnish (the intervention is only available in Finnish) Previous participant exclusion criteria: 1. Current high risk for suicide 2. Psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive-compulsive disorder 3. Not able to read Finnish, Swedish or English well (the intervention is only available in these languages)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Participants’ all-cause sickness absence (cumulative length of sickness absence in days) measured from the employer’s and national administrative records up to 6 months from study entry | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 04/03/2020: Measured from the Finnish Social Insurance Institution’s administrative records and employer’s records up to 6 months from study entry: 1. Long-term sickness absence (over 11 calendar days) for mental disorders 2. Long-term sickness absence (over 11 calendar days) for musculoskeletal disorders 3. Psychotropic medication use 4. Short-term sickness absence spells (up to 11 days) Previous secondary outcome measures: Measured from the Finnish Social Insurance Institution’s administrative records and employer’s records up to 6 months from study entry: 1. Long-term sickness absence (over 11 calendar days) for mental disorders 2. Musculoskeletal disorders 3. Psychotropic medication use 4. Self-certified short sickness absence spells (up to 3 days) | — |
Countries
Finland
Outcome results
None listed